• allemand
• tchèque
• anglais
• italien
• français

Reduction in respiratory motion artefacts on gadoxetate-enhanced MRI after training technicians to apply a simple and more patient-adapted breathing command.
Gutzeit A, Matoori S, Froehlich JM, von Weymarn C, Reischauer C, Kolokythas O, Goyen M, Hergan K, Meissnitzer M, Forstner R, Soyka JD, Doert A, Koh DM.
Eur Radiol. 2016 Aug;26(8):2714-22. doi: 10.1007/s00330-015-4086-4. Epub 2015 Nov 16.

Tumor imaging in patients with advanced tumors using a new (99m) Tc-radiolabeled vitamin B12 derivative.
Sah BR, Schibli R, Waibel R, von Boehmer L, Bläuenstein P, Nexo E, Johayem A, Fischer E, Müller E, Soyka JD, Knuth AK, Haerle SK, Schubiger PA, Schaefer NG, Burger IA.
J Nucl Med. 2014 Jan;55(1):43-9. doi: 10.2967/jnumed.113.122499. Epub 2013 Dec 12.

Combined PET/CT-perfusion in patients with head and neck cancers.
Veit-Haibach P, Schmid D, Strobel K, Soyka JD, Schaefer NG, Haerle SK, Huber G, Studer G, Seifert B, Hany TF.
Eur Radiol. 2013 Jan;23(1):163-73. doi: 10.1007/s00330-012-2564-5. Epub 2012 Jul 8.

Clinical impact of 18F-choline PET/CT in patients with recurrent prostate cancer.
Soyka JD, Muster MA, Schmid DT, Seifert B, Schick U, Miralbell R, Jorcano S, Zaugg K, Seifert HH, Veit-Haibach P, Strobel K, Schaefer NG, Husarik DB, Hany TF.
Eur J Nucl Med Mol Imaging. 2012 Jun;39(6):936-43. doi: 10.1007/s00259-012-2083-2. Epub 2012 Mar 14.

Melanoma of the middle ear: initial presentation, Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography imaging and follow up.
Huellner MW, Cousin M, Linder T, Soyka JD, Bussmann C, Eberle L, Strobel K. J
Laryngol Otol. 2011 May;125(5):536-9. doi: 10.1017/S0022215110002872. Epub 2011 Jan 27.

Continued pemetrexed and platin-based chemotherapy in patients with malignant pleural mesothelioma (MPM): value of 18F-FDG-PET/CT.
Schaefer NG, Veit-Haibach P, Soyka JD, Steinert HC, Stahel RA.
Eur J Radiol. 2012 Jan;81(1):e19-25. doi: 10.1016/j.ejrad.2010.11.006. Epub 2010 Dec 3.

Clinical value of a combined multi-phase contrast enhanced DOPA-PET/CT in neuroendocrine tumours with emphasis on the diagnostic CT component.
Veit-Haibach P, Schiesser M, Soyka J, Strobel K, Schaefer NG, Hesselmann R, Clavien PA, Hany TF.
Eur Radiol. 2011 Feb;21(2):256-64. doi: 10.1007/s00330-010-1930-4. Epub 2010 Aug 15

Influence of bowel preparation before 18F-FDG PET/CT on physiologic 18F-FDG activity in the intestine.
Soyka JD, Strobel K, Veit-Haibach P, Schaefer NG, Schmid DT, Tschopp A, Hany TF.
J Nucl Med. 2010 Apr;51(4):507-10. Epub 2010 Mar 17

Risk-adapted FDG-PET/CT-based follow-up in patients with diffuse large B-cell lymphoma after first-line therapy.
Petrausch U, Samaras P, Haile SR, Veit-Haibach P, Soyka JD, Knuth A, Hany TF, Mischo A, Renner C, Schäefer NG.
Ann Oncol. 2010 Feb 5. [Epub ahead of print]

Increased bone marrow activity on F-18-FDG PET/CT in granulocyte colony stimulating factor producing anaplastic thyroid carcinoma.
Zweifel M, Stenner-Liewen F, Weber A, Samaras P, Zaugg K, Knuth A, Soyka JD.
Clin Nucl Med. 2010 Feb;35(2):103-4. No abstract available.

Hodgkin’s lymphoma in remission after first-line therapy: which patients need FDG-PET/CT for follow-up?
Petrausch U, Samaras P, Veit-Haibach P, Tschopp A, Soyka JD, Knuth A, Hany TF, Mischo A, Renner C, Schaefer NG.
Ann Oncol. 2009 Nov 13. [Epub ahead of print]

Feasibility of integrated CT-liver perfusion in routine FDG-PET/CT.
Veit-Haibach P, Treyer V, Strobel K, Soyka JD, Husmann L, Schaefer NG, Tschopp A, Hany TF.
Abdom Imaging. 2009 Jul 11. [Epub ahead of print]

Combined FDG-PET/CT in response evaluation of malignant pleural mesothelioma.
Veit-Haibach P, Schaefer NG, Steinert HC, Soyka JD, Seifert B, Stahel RA.
Lung Cancer. 2010 Mar;67(3):311-7. Epub 2009 May 30.

Head and neck squamous cell carcinoma (HNSCC)–detection of synchronous primaries with (18)F-FDG-PET/CT.
Strobel K, Haerle SK, Stoeckli SJ, Schrank M, Soyka JD, Veit-Haibach P, Hany TF. Eur J Nucl Med Mol Imaging. 2009 Jun;36(6):919-27. Epub 2009 Feb 10.

FDG-positive Warthin’s tumors in cervical lymph nodes mimicking metastases in tongue cancer staging with PET/CT.
Schwarz E, Hürlimann S, Soyka JD, Bortoluzzi L, Strobel K.
Otolaryngol Head Neck Surg. 2009 Jan;140(1):134-5. No abstract available.

Contrast-enhanced 18F-FDG PET/CT: 1-stop-shop imaging for assessing the resectability of pancreatic cancer.
Strobel K, Heinrich S, Bhure U, Soyka J, Veit-Haibach P, Pestalozzi BC, Clavien PA, Hany TF.
J Nucl Med. 2008 Sep;49(9):1408-13. Epub 2008 Aug 14.

Chemotherapy response assessment in stage IV melanoma patients-comparison of 18F-FDG-PET/CT, CT, brain MRI, and tumormarker S-100B.
Strobel K, Dummer R, Steinert HC, Conzett KB, Schad K, Lago MP, Soyka JD, Veit-Haibach P, Seifert B, Kalff V.
Eur J Nucl Med Mol Imaging. 2008 Oct;35(10):1786-95. Epub 2008 May 6.

Staging pathways in recurrent colorectal carcinoma: is contrast-enhanced 18F-FDG PET/CT the diagnostic tool of choice?
Soyka JD, Veit-Haibach P, Strobel K, Breitenstein S, Tschopp A, Mende KA, Lago MP, Hany TF.
J Nucl Med. 2008 Mar;49(3):354-61. Epub 2008 Feb 20.

Characterization of focal bone lesions in the axial skeleton: performance of planar bone scintigraphy compared with SPECT and SPECT fused with CT.
Strobel K, Burger C, Seifert B, Husarik DB, Soyka JD, Hany TF.
AJR Am J Roentgenol. 2007 May;188(5):W467-74.

Accuracy of 64-slice CT angiography for the detection of functionally relevant coronary stenoses as assessed with myocardial perfusion SPECT.
Gaemperli O, Schepis T, Koepfli P, Valenta I, Soyka J, Leschka S, Desbiolles L, Husmann L, Alkadhi H, Kaufmann PA.
Eur J Nucl Med Mol Imaging. 2007 Aug;34(8):1162-71. Epub 2007 Jan 12.